• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Isogenica

edit

Isogenica Limited, a biotechnology company, develops therapeutic peptides to treat diseases. The company’s vitro display technology, CIS display is used to discover biologically active peptides, proteins, and antibodies. Isogenica Limited was founded in 2000 and is based in Cambridge, the United Kingdom.

Recent Milestones

edit

• 
  Isogenica received () in Venture Round funding. (11/29/12)
  Posted 12/1/12 at 3:21am via yahoo.com
• 
  Isogenica acquired Karyon-CTT. (5/6/08)
  Posted 9/21/09 at 6:45am
• 
  Isogenica added Kevin Matthews as CEO.
  Posted 12/1/12 at 3:25am
• 
  Isogenica added Chris Ullman as CSO.
  Posted 12/1/12 at 3:25am
• 
  Isogenica added Anthony M. Nixon as General Counsel.
  Posted 12/1/12 at 3:25am

Videos

Screenshots

edit

Sources

1. Citation Needed [add]
2. Isogenica Secure Funding from UK’s Technology Strategy Board to Develop Gene Library Synthesis Technology (finance.yahoo.com) [edit]